MyAverix Finance MyAverix Finance

STU · Other

CLINUVEL PHARMACE (UR9.SG) (UR9)

Other

CLINUVEL PHARMACE (UR9.SG) (UR9) is listed on STU in the Other sector. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for UR9

P/E ratio
18.00

CLINUVEL PHARMACE (UR9.SG) (UR9) — FAQ

What is UR9's P/E ratio?

The price-to-earnings (P/E) ratio for CLINUVEL PHARMACE (UR9.SG) (UR9) is 18.00 (data as of 2026-03-22).

Does CLINUVEL PHARMACE (UR9.SG) pay a dividend?

Dividend yield is not available in the current snapshot for CLINUVEL PHARMACE (UR9.SG) (UR9). Check the MyAverix Finance app for the latest dividend data.

What sector is CLINUVEL PHARMACE (UR9.SG) in?

CLINUVEL PHARMACE (UR9.SG) (UR9) is classified in the Other sector.

What exchange is UR9 listed on?

UR9 is listed on STU.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Other companies

Adobe Inc (ADB) AIA GROUP (7A2) Amazon.com Inc (AMZ) AMERICAN EXPRESS (AEC1) Apple Inc (APC) Berkshire Hathaway Inc (BRYN) EXXON MOBIL (XONA) Honeywell International Inc (ALD)

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play